(Q30437479)

21 June 2017

title

Local immunomodulation with CD4 and CD8 antibodies, but not cyclosporine A, improves osteogenesis induced by ADhBMP9 gene therapy (English)

1 reference

21 June 2017

0 references

1 reference

Li JZ

1

1 reference

21 June 2017

Li H

2

1 reference

21 June 2017

Hankins GR

3

1 reference

21 June 2017

Dunford B

4

1 reference

21 June 2017

Helm GA

5

1 reference

21 June 2017

language of work or name

1 reference

1 August 2005

1 reference

21 June 2017

1 reference

21 June 2017

volume

12

1 reference

21 June 2017

issue

16

1 reference

21 June 2017

page(s)

1235-1241

1 reference

The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

The family of bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

The application of bone morphogenetic proteins to dental tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Simple and effective osteoinductive gene therapy by local injection of a bone morphogenetic protein-2-expressing recombinant adenoviral vector and FK506 mixture in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

The time course study of osteoinduction by bone morphogenetic protein-2 via adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Mechanisms of action of cyclosporine and effects on connective tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Rat strain differences in the ectopic osteogenic potential of recombinant human BMP adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Signal transduction of bone morphogenetic protein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Upregulation of acetylcholine synthesis by bone morphogenetic protein 9 in a murine septal cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Morphologic analysis of BMP-9 gene therapy-induced osteogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

The effects of recombinant human interleukin-1 beta on cellular proliferation and the production of prostaglandin E2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Two major Smad pathways in TGF-beta superfamily signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Smad proteins physically interact with calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Effect of FK506 on osteoinduction by recombinant human bone morphogenetic protein-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Effect of cyclosporin A on alveolar bone homeostasis in a rat periodontitis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Cyclosporine A delivery to the eye: A pharmaceutical challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Effect of macrophage-derived apolipoprotein E on established atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

Cyclosporin A. Mode of action and effects on bone and joint tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

7 January 2021

Transforming growth factor-beta administration modifies cyclosporine A-induced bone loss

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

7 January 2021

Interferon-alpha, unlike interferon-gamma, does not cause bone loss in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

7 January 2021

Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

7 January 2021

Actions of recombinant human gamma-interferon and tumor necrosis factor alpha on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

7 January 2021

Natural human IL-1 beta exhibits regulatory actions on human bone-derived cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

7 January 2021

The effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on human osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

7 January 2021

Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302502

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302502

1 reference

Dimensions Publication ID

21 June 2017

1003513427

0 references

1 reference